Robert Ruffolo

Robert R.
Ruffolo is the founder of Ruffolo Consulting LLC, established in 2008, where the title held is Managing Director.
Current jobs include Director at Biotechnology Innovation Organization, Independent Director at Elicio Therapeutics, Inc. since 2018, Director at eXIthera Pharmaceuticals, Inc., Director at Aragen Life Sciences Pvt Ltd. since 2019, Director at Ocuterra Therapeutics, Inc. since 2021, Director at Sapience Therapeutics, Inc., Director at Nacuity Pharmaceuticals, Inc. since 2021, Director at Neuraptive Therapeutics, Inc. since 2022, Director at Elucida Oncology, Inc., Director at Combined Therapeutics, Inc. since 2023, Independent Director at LB Pharmaceuticals, Inc. since 2019, and President at Wyeth Research since 2000.
Former jobs include Senior VP & Director-Biological Sciences at GSK Plc from 1984 to 2000, Director at The West Virginia University Foundation, Inc., Director at Trevena, Inc. from 2009 to 2013, Independent Director at Aridis Pharmaceuticals, Inc. from 2016 to 2023, Independent Director at Diffusion Pharmaceuticals, Inc. from 2017 to 2019, Independent Director at Sigilon Therapeutics, Inc. from 2016 to 2023, Director at Lipidio Pharmaceuticals, Inc., Senior Vice President at Wyeth LLC, and President-Research & Development, Senior VP at Wyeth Pharmaceuticals LLC from 2000 to 2008.
Education includes undergraduate and doctorate degrees from The Ohio State University, conferred in 1973 and 1976 respectively.